Fate Therapeutics Inc. (FATE)
1.03
-0.09 (-8.04%)
At close: Mar 03, 2025, 1:10 PM
Fate Therapeutics Ratios Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
| PE Ratio | -2.29 | -3.83 | -26.87 | -43.99 | -13.66 | -10.83 | -5.97 | -2.38 | -2.86 | -3.97 | -1.77 | -4.12 | -4.37 |
| PEG Ratio | 0.06 | -0.19 | -5.06 | -0.98 | -0.68 | -0.65 | 2.09 | 0.22 | 0.40 | 0.06 | -0.01 | -0.62 | n/a |
| PS Ratio | 5.79 | 10.15 | 99.27 | 238.32 | 124.95 | 152.11 | 62.47 | 18.11 | 35.33 | n/a | 38.13 | 21.98 | 50.17 |
| PB Ratio | 1.00 | 2.02 | 8.17 | 19.49 | 5.45 | 4.49 | 3.32 | 1.09 | 2.26 | 3.63 | 0.73 | -1.11 | -1.16 |
| P/FCF Ratio | -2.66 | -3.44 | -25.96 | -169.64 | -14.73 | -17.61 | -6.64 | -2.63 | -4.32 | -4.41 | -2.37 | -4.2 | -4.83 |
| P/OCF Ratio | -2.78 | -3.94 | -34.04 | -190.96 | -16.04 | -18.65 | -6.95 | -2.67 | -4.67 | -4.59 | -2.41 | -4.42 | -4.83 |
| OCF/S Ratio | -2.08 | -2.58 | -2.92 | -1.25 | -7.79 | -8.15 | -8.99 | -6.77 | -7.57 | n/a | -15.83 | -4.97 | -10.38 |
| Debt / Equity Ratio | 0.28 | 0.23 | 0.17 | 0.25 | 0.11 | 0.09 | 0.19 | 0.15 | 0.48 | 0.69 | 0.03 | -0.07 | -0.1 |
| Quick Ratio | 8.48 | 4.40 | 7.79 | 5.78 | 8.17 | 7.53 | 9.29 | 6.14 | 4.88 | 10.89 | 11.88 | 2.02 | 1.82 |
| Current Ratio | 8.48 | 4.40 | 7.79 | 5.78 | 8.17 | 7.53 | 9.29 | 6.14 | 4.88 | 10.89 | 11.88 | 2.02 | 1.82 |
| Asset Turnover | 0.13 | 0.14 | 0.06 | 0.05 | 0.04 | 0.02 | 0.04 | 0.05 | 0.04 | n/a | 0.02 | 0.24 | 0.15 |
| Interest Coverage | n/a | -52.79 | n/a | n/a | -57.49 | -39.56 | -33.22 | -19.53 | -12.51 | -45.36 | -22.2 | -27.84 | -104.67 |
| Return on Equity (ROE) | -0.44 | -0.53 | -0.3 | -0.44 | -0.4 | -0.42 | -0.56 | -0.46 | -0.79 | -0.91 | -0.41 | 0.27 | 0.26 |
| Return on Assets (ROA) | -0.32 | -0.36 | -0.22 | -0.27 | -0.32 | -0.31 | -0.41 | -0.35 | -0.44 | -0.51 | -0.38 | -1.29 | -1.71 |
| Return on Capital (ROIC) | -0.41 | -0.52 | -0.26 | -0.24 | -0.37 | -0.36 | -0.45 | -0.4 | -0.51 | -0.53 | -0.35 | -2.18 | -3.18 |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | -154.51% | 85.71% | 89.52% | -299.64% | -721.82% | -1.08K% | -736.78% | -500.91% | -716.99% | n/a | -1.14K% | -349.4% | 100.00% |
| Net Profit Margin | -253.3% | -264.86% | -369.41% | -541.77% | -914.87% | -1.41K% | -1.05K% | -760.15% | -1.23K% | n/a | -2.15K% | -533.3% | -1.15K% |
| Pretax Profit Margin | -253.3% | -292.55% | -379.89% | -551.59% | -919% | -1.41K% | -1.05K% | -760.15% | -1.23K% | n/a | -2.15K% | -533.3% | -1.15K% |
| Operating Profit Margin | -299.86% | -320.23% | -388.56% | -407.47% | -943.14% | -1.42K% | -1.03K% | -726.1% | -1.14K% | n/a | -1.82K% | -507.75% | -1.14K% |
| FCF Margin | -217.86% | -294.68% | -382.43% | -140.49% | -848.03% | -863.99% | -940.82% | -687.87% | -818.39% | n/a | -1.61K% | -523.71% | -1.04K% |
| EBITDA Margin | -271.09% | -305.95% | -378.08% | -397.65% | -882.06% | -1.34K% | -991.55% | -702.95% | -1.11K% | n/a | -2.01K% | -492.96% | -1.08K% |